openPR Logo
Press release

IVD Raw Materials Market to Reach $34.25 Billion by 2027. Molecular Point-of-Care (POC) Replacing Existing Limitations at POC sites - Arizton

According to Arizton's latest research report, the IVD raw materials market is growing at a CAGR of 5.86% during the forecast period. The increasing prevalence of infectious & chronic diseases, growing awareness of early diagnosis and disease prevention, and rise in availability of advanced home care kits for cancer diagnostics are the major drivers in the market.
Molecular Point-of-Care (POC) testing has also expanded the diagnostic capabilities and overcome existing limitations at POC sites, such as critical care centers, outpatient clinics, physician offices, and other ambulatory care settings. Consequently, the total market potential of molecular POC diagnostics has increased considerably to offer tremendous growth opportunities in the future.

To get a free sample report click: https://www.arizton.com/request-sample/3299

IVD medical devices have become a major sector in the field of diagnosis, leading to major advances. Such factors are accelerating the adoption of IVDs and there is a simultaneous demand for its raw materials. Furthermore, the growing trends of POC diagnostics and personalized medicine are contributing to the growth of the market. The surge in adoption of antigen-antibody testing and point-of-care diagnostics has enabled the growth of the pharma & biotech companies segment. The segment is also expected to witness the highest incremental growth of $6.35 billion during the forecast period. However, the diagnostic laboratories segment is likely to witness the highest absolute growth of 43.37% during the forecast period.

KEY INSIGHTS
• The rise in demand for diagnostics and laboratory tests attributable to the surge in the patient population due to the prevalence of chronic diseases is increasing the demand for IVD raw materials.
• The global IVD raw materials market is segmented by product, technology, end-user, and geography.
• In 2021, antibodies & antigens accounted for the highest share of over 36.00% in the global IVD raw materials market due to the growing demand for antigen and antibody-based tests that increased during COVID-19.
• In 2021, clinical chemistry accounted for the highest share of more than 37.00% in the global IVD raw materials market with the growing number of hospitalizations and laboratory tests led by clinical chemistry.
• In 2021, pharma & biotech companies accounted for the highest revenue share of over 62.00% in the global IVD raw materials market, due to the growing number of antigen-antibody testing centers, point of care diagnostics, and pharma & biotech companies.
• In 2021, Europe is dominating the global IVD raw materials market with the highest share of over 34.00% due to the availability of advanced IVD devices and various developments in lab automation.

Major manufacturers of IVD raw materials are focusing on proprietary processing techniques to satisfy the raw material requirements of the IVD industry and provide IVD raw materials manufactured using off-the-shelf specifications. Also, several international players are focusing on the development of innovative products and expanding their product portfolio to ensure a sustainable presence in the market. Additionally, many vendors are constantly investing in R&D initiatives based on market trends and general health management demands. Vendors are also focusing on developing and commercializing innovative analyzers, COVID-19 PCR rapid test kits, and consumables to remain competitive and establish a significant presence in the market. For instance, Adaltis S.r.l. develops, manufactures, and markets IVD systems and reagents and offers a wide range of consumables such as tips, vials, and tubes. These vendors are actively launching innovative devices to penetrate and tap the tremendous growth potential in the market.

To know more: https://www.arizton.com/market-reports/ivd-raw-materials-market

ABOUT ARIZTON:
Arizton Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
We offer comprehensive market research reports on industries such as consumer goods & retail technology, automotive and mobility, smart tech, healthcare, and life sciences, industrial machinery, chemicals, and materials, IT and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.
Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.

Arizton Advisory and Intelligence
Call: +1-312-235-2040
+1 302 469 0707

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release IVD Raw Materials Market to Reach $34.25 Billion by 2027. Molecular Point-of-Care (POC) Replacing Existing Limitations at POC sites - Arizton here

News-ID: 2653870 • Views:

More Releases for IVD

Transformative Trends Impacting the Cancer In Vitro Diagnostics (IVD) Market Lan …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Cancer In Vitro Diagnostics (IVD) Market Size By 2025? The market size for cancer in vitro diagnostics (IVD) has seen significant growth in the past few years. The market value, which is expected to be $13.36 billion in 2024, is projected to increase to $14.32
In Vitro Diagnostics (IVD) Market
With the watchful use of established and advanced tools such as SWOT analysis and Porter's Five Forces Analysis, this market report has been structured. While preparing this In Vitro Diagnostics (IVD) Market research report, few of the attributes that have been adopted include highest level of spirit, practical solutions, committed research and analysis, innovation, integrated approaches, and most up-to-date technology. Every possible effort has been taken while researching and analysing
Companion Animal IVD Market - Guiding the Path to Optimal Health: Empowering Vet …
Newark, New Castle, USA - new report, titled Companion Animal IVD Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Companion Animal IVD market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Companion Animal IVD market. The report offers an overview of
IVD Market 2021 | Detailed Report
The IVD market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The IVD report also incorporates the current and future global market outlook in the emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period. The IVD research report also provides insights of different regions that are contributing market growth.
Liquid Biopsy IVD Market 2021 | Detailed Report
According to Market Study Report, Liquid Biopsy IVD Market provides a comprehensive analysis of the Liquid Biopsy IVD Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample PDF (including full TOC, Tables and Figures) of Liquid Biopsy IVD Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4623688 The report provides a
Asia IVD Market
According to a new report published by Allied Market Research, the Asia Pacific In-vitro diagnostics market was valued at $12.9 billion in 2015, and is expected to reach $19.0 billion registering a CAGR of 5.6% during 2016 to 2022. The report offers a detailed analysis of the key segments, top investment pockets, changing dynamics, market size & estimations, and competitive scenario. Download Free Sample Report @ https://www.alliedmarketresearch.com/request-sample/1256 The Asia-Pacific IVD market is